Skip to content
★ Sign in to follow
BP

Barton P. Bandy

Executive
Chief Executive Officer
ReShape Lifesciences Inc.
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€871k

Latest filing published 11 Aug 2022 for ReShape Lifesciences Inc., €5,354.

Filing timeline

BuySale
Barton P. Bandy

Insider track record

Disclosed buys
0
Disclosed sells
13

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Barton P. Bandy: trading record in brief

This profile gathers the share dealings of Barton P. Bandy in ReShape Lifesciences Inc., where the filings describe the role as chief executive. In total, 15 filings cover trades dated from 22 July 2021 to 5 August 2022.

Every open-market trade on record is a sale: 13 sales worth €871k. The rest of the record consists of 2 share grants. 2022 to date brings no purchases and 9 sales.

On 11 August 2022 came the latest disclosure, an open-market sale for €5,354 in ReShape Lifesciences Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 7 days. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Barton P. Bandy

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations12 total

12 of 12 declarations